Explorative Trial Evaluating the Efficacy and Tolerability of LEO43204 in Moderate to Severe Acne
- First Posted Date
- 2015-10-15
- Last Posted Date
- 2019-02-28
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 59
- Registration Number
- NCT02575950
- Locations
- 🇺🇸
Torrance Clinical Research Institute Inc., Lomita, California, United States
LEO 124249 Ointment in the Treatment of Alopecia Areata
- First Posted Date
- 2015-09-28
- Last Posted Date
- 2019-04-16
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 40
- Registration Number
- NCT02561585
- Locations
- 🇺🇸
The Icahn School of Medicine, Mount Sinai Hospital, New York, New York, United States
🇺🇸Northwestern University, Evanston, Illinois, United States
Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Balding Scalp Including 12-month Follow-up
- First Posted Date
- 2015-09-15
- Last Posted Date
- 2018-12-26
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 391
- Registration Number
- NCT02549352
- Locations
- 🇩🇪
Klinik für Dermatologie & Allergologie Klinikum Vest GmbH, Recklinghausen, Germany
Efficacy and Safety of LEO 43204 in the Field Treatment of Actinic Keratosis on Face or Chest including12-month Follow-up
- First Posted Date
- 2015-09-15
- Last Posted Date
- 2018-12-05
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 383
- Registration Number
- NCT02549339
- Locations
- 🇺🇸
Laser & Skin Surgery Center of Indiana, Carmel, Indiana, United States
Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Face or Chest Including 12-month Follow-up
- First Posted Date
- 2015-09-11
- Last Posted Date
- 2018-12-26
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 437
- Registration Number
- NCT02547233
- Locations
- 🇺🇸
Altman Dermatology Associates, Arlington Heights, Illinois, United States
Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Balding Scalp Including 12-month Follow-up
- First Posted Date
- 2015-09-11
- Last Posted Date
- 2018-12-26
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 373
- Registration Number
- NCT02547363
- Locations
- 🇺🇸
Long Island Skin Cancer & Dermatologic Surgery, Smithtown, New York, United States
Long-term Treatment of Scalp Psoriasis With Xamiol® Gel in a Large Adult Chinese Population
- Conditions
- Interventions
- First Posted Date
- 2015-08-27
- Last Posted Date
- 2018-12-20
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 951
- Registration Number
- NCT02533973
- Locations
- 🇨🇳
The Second Affiliated hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
A Psoriasis Plaque Test Trial With LEO 90100 Compared to Betesil® in Patients With Psoriasis Vulgaris
- Conditions
- Interventions
- First Posted Date
- 2015-08-07
- Last Posted Date
- 2024-08-29
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 35
- Registration Number
- NCT02518048
- Locations
- 🇫🇷
Centre de Pharmacologie Clinique Appliquée à la Dermatologie (CPCAD), Nice, France
LEO 32731 - A Phase I Study in Healthy Subjects
- First Posted Date
- 2015-08-04
- Last Posted Date
- 2017-05-03
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 27
- Registration Number
- NCT02514694
- Locations
- 🇬🇧
Covance CRU, Leeds, United Kingdom
An Explorative Trial Evaluating the Effect of LEO 32731 Cream in Adults With Mild to Moderate Atopic Dermatitis (AD)
- Conditions
- Interventions
- First Posted Date
- 2015-07-14
- Last Posted Date
- 2017-05-03
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 30
- Registration Number
- NCT02496546
- Locations
- 🇩🇪
Proinnovera GmbH, Center of Dermatology Excellence, Münster, Germany